Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Human Brain Mapping|January 18, 2022
Functional connectome mediates the association between sleep disturbance and mental health in preadolescence: A longitudinal mediation studyFan Nils Yang, Tina Tong Liu, Ze WangJournal of Child Psychology and Psychiatry, and Allied Disciplines|May 29, 2023
Corticostriatal connectivity mediates the reciprocal relationship between parent-reported sleep duration and impulsivity in early adolescentsFan Nils Yang, Tina Tong Liu, Ze WangNeuroimage|November 13, 2019
Effects of unilateral cortical resection of the visual cortex on bilateral human white matterAnne Margarette S Maallo, Erez Freud, Tina Tong Liu, et al.Vaccine|November 28, 2017
Workshop report: Nucleic acid delivery devices for HIV vaccines: Workshop proceedings, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA, May 21, 2015Bruce G Weniger, Ian E Anglin, Tina Tong, et al.Communications Medicine|September 1, 2022
Leveraging lessons learned from the COVID-19 pandemic for HIVThomas Calder, Tina Tong, Dale J Hu, et al.The Journal of Clinical Investigation|September 15, 2022
Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 monthsMagdalena E Sobieszczyk, Jill Maaske, Ann R Falsey, et al.Frontiers in Immunology|January 30, 2023
Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinatedJill Maaske, Stephanie Sproule, Ann R Falsey, et al.JAMA Network Open|January 23, 2023
Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine TrialsAlfredo J Mena Lora, Jessica E Long, Yunda Huang, et al.Journal of Virology|May 15, 2015
Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine ResearchLindsay Wieczorek, Shelly J Krebs, Vaniambadi Kalyanaraman, et al.NPJ Vaccines|April 18, 2026
Correlates of severe and delta COVID-19 in a phase 3 trial of the AZD1222 vaccineHolly Janes, Youyi Fong, Ying Huang, et al.Pageof 2